The Multiple Sclerosis Emerging Therapies Collaborative – which includes the MS Coalition, the American Academy of Neurology, and the VA Multiple Sclerosis Centers of Excellence East and West – is committed to developing and disseminating timely, evidence-based resources to persons affected by multiple sclerosis and health care professionals, in order to promote optimal, individualized treatment of the disease by facilitating effective communication and medical decision-making. Launched in 2011, the Collaborative has as its priority to provide information on MS-specific, US Food and Drug Administration (FDA)-approved treatments that have entered the market since 2010. Previously-approved medications will be reviewed in the event of new safety or efficacy data that significantly affect their use in MS treatment.
For more information visit their website at
Last Updated: June 6, 2011